
Conor Stewart
Research expert covering health & pharmaceuticals in the UK & Europe
Get in touch with us nowThe chart is not accessible to screen readers. Please switch to the table view to access the data.
Marijuana is by far the most used illicit drug in the United States, with over 64 million people using this drug in 2024. The second most used drug at that time was cocaine, followed by methamphetamine and ecstasy. The United States has had a complicated history with drugs, from fighting a 鈥淲ar on Drugs鈥 starting in the 1970s, to seeing the legalisation of marijuana in many states, and experiencing an ongoing nationwide opioid overdose epidemic.聽
Although marijuana is still illegal under federal law, 21 states have legalized the recreational use of marijuana. This legalization has opened a new and thriving market in these states. It is estimated that sales of legal cannabis will reach around 25 billion U.S. dollars by the year 2025. Although support for the legalization of marijuana has not always been strong, now around 68 percent of U.S. adults believe it should be made legal.
The opioid epidemic describes a rise in overdose deaths in the U.S. due to prescription opioids, heroin, and illegally manufactured synthetic opioids such as fentanyl. The epidemic stems from misleading information from pharmaceutical companies concerning the dangers of opioids such as oxycontin, overprescribing of opioids from physicians, and an influx of easily accessible heroin and highly potent synthetic opioids. In 2022, there were around 81,806聽deaths from opioid overdose in the United States.
* For commercial use only
Basic Account
Starter Account
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Smoking
Alcohol
Weight
Drug use
Sex
Stress
* For commercial use only
Basic Account
Starter Account
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.